Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia

Per-Ola Attman

首页> 外文期刊>Nephrology Dialysis Transplantation >Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia

【24h】

Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia

机译：使用直接凝血酶抑制剂美拉加群预防慢性尿毒症患者血液透析期间的血块形成

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Nephrology Dialysis Transplantation》 |2006年第6期|1738-1738|共1页
作者
Per-Ola Attman;
展开▼
作者单位

Department of Nephrology Sahlgrenska University Hospital Göteborg Sweden;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia. [J] . Attman PO Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association . 2006,第6期

机译：在慢性尿毒症患者中使用直接凝血酶抑制剂美拉加群预防血液透析过程中的血块形成。
2. Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia. [J] . Attman PO, Ottosson P, Samuelsson O, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association . 2005,第9期

机译：在慢性尿毒症患者中使用直接凝血酶抑制剂美拉加群预防血液透析过程中的血块形成。
3. Prolongation of clot lysis time by a direct thrombin inhibitor melagatran mediated by paradoxical enhancement of thrombin generation: comparison with a direct factor Xa inhibitor edoxaban [J] . Yoshiyuki Morishima, Chikako Kamisato, Yuko Honda Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis . 2021,第3期

机译：凝血酶抑制剂Melagatran延长凝血酶抑制剂Melagatran鉴定凝血酶产生介导：与直接因子Xa抑制剂Edoxaban的比较
4. Clot permeable peptide inhibitors of thrombin and factor Xa [C] . Sandor Bajdusz, Eva Barabas, Iren Fauszt, European Peptide Symposium . 2002

机译：凝血酶的渗透肽抑制剂和因子xa
5. Discovery of inactive E* conformations in thrombin and other vitamin K-dependent clotting proteases. [D] . Bah, Alaji. 2009

机译：在凝血酶和其他依赖维生素K的凝血蛋白酶中发现非活性E *构象。
6. Editors Choice: Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding safety and tolerability study of four doses of AZD0837 vs. vitamin K antagonists [O] . Gregory Y.H. Lip, Lars H. Rasmussen, S. Bertil Olsson, -1

机译：编辑推荐：口服直接凝血酶抑制剂AZD0837用于预防非瓣膜性房颤患者的中风和全身性栓塞：四种剂量AZD0837和维生素K拮抗剂的随机剂量指导安全性和耐受性研究
7. Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia [O] . Per-Ola Attman, Pia Ottosson, Ola Samuelsson, 2005

机译：使用直接凝血酶抑制剂Melagatran在慢性尿血症患者中预防血液透析过程中的凝块形成

Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia

著录项

相似文献

相关主题

期刊订阅